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17 The NHS ‘Heart Age Test’ has expanded CVD risk assessment in the UK to include younger 
18 people. Public Health England’s ‘Healthy Heart’ campaign, launched in September 2018, 
19 encourages all adults aged 30+ years to do the test (see Figure 1), stating: “Having a heart age 
20 older than your chronological age means that you are at a higher risk of having a heart attack or 
21 stroke.” But does older heart age really mean high risk? The calculator will give you an older age 
22 if at least one CVD risk factor is higher than the level set as ‘optimal’; but this does not 
23 necessarily mean you are at high risk of a CVD event in the next 10 years, as shown by the 
24 examples in Figure 1. Is there evidence to support PHE’s promotion of the heart age test? To find 
25 out, we evaluated the ‘Heart Age Test’ according to Public Health England’s own National 
26 Screening Committee criteria. This analysis suggests heart age is not a good screening test. 
27
28 Figure 1. NHS ‘Heart Age Test’ [INSERT FIGURE 1 HERE] 
29 Caption: Heart Age Test results for a 35 year-old woman at low risk of CVD (Case 1,Table 1).
30
31 1. The condition should be an important health problem as judged by its frequency and/or 
32 severity. CVD is an important health problem. The rate of death from CVD has declined 
33 throughout the UK in the last 3 decades,(1) but CVD remains the leading cause of death in men 
34 and second leading cause of death in women, with around 160,000 people in the UK dying from 
35 CVD every year. 
36
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37 2. There should be a simple, safe, precise and validated screening test. Though the ‘Heart 
38 Age Test’ calculator is simple and physically safe to use, it is not precise or validated. Heart age 
39 is estimated from the lifetime risk of CVD, relative to people of the same age, gender and 
40 ethnicity who have ‘optimal’ risk factor levels (e.g. non-smoker, systolic blood pressure <120 
41 mm Hg).(2) The authors of the last update of the NICE guidelines on CVD risk assessment in 
42 2014 found insufficient evidence to recommend lifetime risk as a validated screening test. There 
43 is even less evidence for indirect measures of lifetime risk, such as heart age. 
44
45 3. The distribution of test values in the target population should be known and a suitable 
46 cut-off level defined and agreed. The ‘Heart Age Test’ targets everyone aged 30+ years, and is 
47 disproportionately used by younger people <40 years.(2) In contrast, formal CVD risk 
48 assessment as part of NHS Health Checks targets people ≥40 years. According to Public Health 
49 England, of two million ‘Heart Age Test’ users the majority (78%) had older heart age. All are 
50 prompted to visit a GP and described as having ‘increased risk of heart disease’, but there has 
51 been no assessment on the suitability of [heart age – chronological age] >0 as a cut-off level to 
52 prompt further testing.
53
54 4. The test, from sample collection to delivery of results, should be acceptable to the target 
55 population. The acceptability of heart age depends on whether it matches users’ expectations. A 
56 ‘think aloud’ study found that older heart age was confronting and discredited by users if it did 
57 not match prior risk perception; while younger heart age was viewed as positive but 
58 unrealistic.(3) A randomised trial confirmed that heart age was perceived as less credible and 
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59 elicits more negative emotions compared to absolute CVD risk.(4) Further acceptability issues 
60 are highlighted by public responses (Supplement 1).
61
62 5. There should be an agreed policy on the further diagnostic investigation of individuals 
63 with a positive test result and on the choices available to those individuals. There is no 
64 agreed policy on further investigation of individuals with older heart age results (i.e. 78% of 
65 users). It prompts people to have an NHS Health Check, which is recommended for those over 
66 40 and which itself is controversial. A Cochrane review found no evidence that these checks are 
67 beneficial, and they may even cause harm through the diagnosis and treatment of conditions 
68 unlikely to cause symptoms or death (i.e. overdiagnosis and overtreatment).(5) Encouraging 
69 large numbers of asymptomatic young people to have their blood pressure and cholesterol 
70 measured is not an agreed policy with the RCGP or the UK National Screening Committee.
71
72 6. There should be agreed evidence-based policies covering which individuals should be 
73 offered interventions and the appropriate intervention to be offered. Convincing patients 
74 with CVD risk factors to change their lifestyle is important at any age, and heart age could be 
75 used for this.(6) An RCT found that online assessment of heart age can improve risk factor 
76 management compared to verbal counselling about absolute risk.(7) However, direct 
77 experimental comparisons between heart age and absolute risk have found no effect on lifestyle 
78 intentions or behaviour.(4) Where heart age has motivated lifestyle change, this has been within 
79 a clinical context. This is quite different to a pre-consultation screening test, where existing 
80 lifestyle and circumstances are not taken into account, resulting in implausible heart age 
81 estimates that discredit the results (e.g. older heart age in very fit people, or younger heart age in 
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82 obese people).(3) Medication guidelines recommend assessing the absolute risk of a CVD event 
83 and prioritising treatment to those at highest risk who are most likely to benefit.(8) Absolute risk 
84 is preferred for treatment decisions, rather than single risk factors such as blood pressure (9) or 
85 cholesterol. Heart age is an ill-defined measure of risk, relative to others of the same age, gender 
86 and ethnicity with optimal risk factor levels.(3,10) As it is not a measure of absolute risk, it is not 
87 helpful for medication decisions.(4,10) 
88
89 7. There should be evidence from high quality randomised controlled trials that screening 
90 is effective in reducing mortality or morbidity. There is evidence for several interventions that 
91 might be prompted through heart age screening, including smoking advice and lowering blood 
92 pressure/cholesterol. However, the Cochrane review of health checks shows that promoting these 
93 in a non-targeted way has no impact on actual CVD,(5) possibly because it attracts people at 
94 lower, rather than higher, risk. Since predominantly younger people use the ‘Heart Age Test’,(2) 
95 it may exacerbate the problem of low risk people attending health checks. There is no trial 
96 evidence that using heart age to screen for CVD risk or prompt formal CVD assessment reduces 
97 mortality or morbidity.
98
99 8. The benefit gained by individuals from the screening programme should outweigh any 
100 harms.  The ‘Heart Age Test’ has no direct evidence of benefit, and there is potential for harm. 
101 Heart age results may lead high risk people to disregard relevant risk information if they don’t 
102 believe the results, and cause low risk people to worry and seek unnecessary tests.(3,4) Other 
103 potential harms include negative psychological and behavioural effects of disease labelling, 
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104 physical harms and side effects of unnecessary tests or treatment for CVD, hassles and cost of 
105 unnecessary tests and treatments, wasted resources and opportunity costs to the health system. 
106 These harms, which contribute to overmedicalisation of society in general,(11) should not be 
107 underestimated. 
108
109 9. The opportunity cost of the screening programme (including testing, diagnosis and 
110 treatment, administration, training and quality assurance) should be economically 
111 balanced in relation to expenditure on medical care as a whole. The ‘Heart Age Test’ tells 
112 anyone over 30 to make an appointment with their GP, nurse or pharmacist to have their 
113 cholesterol level or blood pressure measured if this is unknown. This may add to GPs’ already 
114 overburdened workload, increase waiting times and detract attention from necessary high value 
115 care/ treatments for patients who are unwell. 
116
117 10. Evidence-based information, explaining the purpose and potential consequences of 
118 screening, investigation and preventative intervention or treatment, should be made 
119 available to potential participants to assist them in making an informed choice. There is 
120 very little published information explaining what exactly heart age represents to enable an 
121 informed choice on whether or not to use it. As a GP wrote recently in The BMJ Opinion:
122 “I’ve looked at the supporting documents and can’t find any answers. Perhaps they’re 
123 there if you dig deep enough through the JBS3 website (which the tool points you 
124 towards), but that’s not the point. If I can’t find the answer after 20 minutes of looking, 
125 who else is going to bother? The public deserve to know how accurate these estimates 
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126 are. Presenting uncertainty as fact is not what the public, or our patients, want or need.” 
127 (BMJ Blogs, 2018 Sept 12)
128 The ‘Heart Age Test’ provides no information about who should use it, recommends cholesterol 
129 and blood pressure testing for everyone who does not enter values for these, and provides no 
130 information about the potential benefits, harms and costs of having these additional tests done 
131 and of taking any medication which might subsequently be offered.(10) It is therefore not 
132 possible to make an informed choice about using it.(12) Furthermore, the ‘Heart Age Test’ may 
133 confuse people when heart age and absolute risk are contradicting (e.g. low risk but heart age 




138 The ‘Heart Age Test’ is effectively a screening test that expands CVD risk assessment to include 
139 younger people without proper consultation or informed co sent. It encourages almost 80% of – 
140 mostly young – users to see their GP for further medical interventions. Apart from being a test 
141 for an important condition (CVD), the ‘Heart Age Test’ meets none of the National Health 
142 England’s own assessment criteria for a potentially useful screening test. As stated in a recent 
143 article about the de-adoption of ineffective clinical practices: 
144 “We need to take a more cautious approach to technology adoption, and learn from 
145 mistakes of early adoption of health care technologies based on little or low-quality 
146 clinical evidence. This way we can prevent the need to ‘break up’ with the practice when 
147 the high-quality evidence shows that it is ineffective.” (New York Times, 2018 Sept 11)
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148 The NHS might do well to take this advice before adopting and promoting online technologies 
149 such as heart age calculators. The results of heart age calculators should be limited to lifestyle 
150 advice, ideally within the setting of the clinical consultation, to avoid inadvertent population 
151 screening for CVD using an unvalidated screening test.
152
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Heart Age Test results for a 35 year-old woman at low risk of CVD (Case 1,Table 1) 
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